Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Nanosphere Inc's verigene enteric pathogens test receives FDA clearance


Tuesday, 24 Jun 2014 06:00pm EDT 

Nanosphere Inc:Receives U.S. Food and Drug Administration (FDA) 510(k) clearance for the bacterial portion of its Verigene┬« Enteric Pathogens Nucleic Acid Test (EP).Clinical studies for the full panel, including two additional viral targets, have been completed and the Company expects clearance of the full EP panel. 

Company Quote

0.4121
0.0013 +0.32%
12:46pm EST